Oncology Institute (TOI) Depreciation and Depletion (2021 - 2026)

Oncology Institute has reported Depreciation and Depletion for 6 years, with the latest figure at $901000.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion fell 10.88% year-over-year to $901000.0; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 10.46% YoY), and the FY2025 full-year result was $4.0 million, up 24.15% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $901000.0, down from $915000.0 in the prior quarter.
• The five-year high for Depreciation and Depletion was $1.0 million in Q2 2025, with the low at $314000.0 in Q1 2022.
• Historically, Depreciation and Depletion has averaged $732235.3 across 5 years, with a median of $800000.0 in 2024.
• Annual changes were most pronounced in 2023 — Depreciation and Depletion surged 132.57% — and 2024, when it fell 12.47%.
• Oncology Institute's Depreciation and Depletion stood at $460000.0 in 2022, then jumped by 75.65% to $808000.0 in 2023, then advanced by 15.47% to $933000.0 in 2024, then decreased by 1.93% to $915000.0 in 2025, then retreated by 1.53% to $901000.0 in 2026.
• The last three Depreciation and Depletion figures came in at $901000.0 (Q1 2026), $915000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.